To the left find scientific theory for the basis of Prokarin™.

For further information about MS, check the links below.
Transdermal histamine in multiple sclerosis, Part 1.
Transdermal histamine in multiple sclerosis, Part 2.
The Pathogenesis of Multiple Sclerosis Revisited

Scientists at the Neuroimmunology and Neuromuscular Disorders Unit at the Neurological Institute Foundation Carlo Besta in Milan, Italy have demonstrated in animals that histamine may be a promising treatment for MS in humans. MS patients using Prokarin™ since 1999 have already confirmed these benefits of histamine acting on the H2 receptor in alleviating or lessening their symptoms. http://www.sciencedaily.com/releases/2011/01/110131133317.htm